|
Code
|
15869
|
|
MA number
|
15/0243/13-S
|
|
Product Form:
|
tbl flm 10x250 mg (blis.OPA/Al/PVC)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
MAH, country:
|
Sandoz Pharmaceuticals d.d., Slovenia
|
|
Therapeutic Class:
|
15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J01 |
ANTIBACTERIALS FOR SYSTEMIC USE |
| J01D |
OTHER BETA-LACTAM ANTIBACTERIALS |
| J01DC |
Second-generation cephalosporins |
| J01DC02 |
Cefuroxime |
|
|
Shelf life:
|
36 |
|
Container:
|
blister OPA/Al/PVC
|
|
Route of admin.:
|
Oral use
|
PIL_Zinnat 125 mg 250 mg 500 mg tbl flm_06.2024.pdf
